December 2020

Teams from across BC join the BOOST QI Network Annual Congress virtually

The Best-practices in Oral Opioid AgoniSt Therapy (BOOST) Annual Congress was held last month amidst the dual public health emergencies of the COVID-19 pandemic and the opioid overdose crisis. Presenters at the congress shared how their teams are adapting their practices for the pandemic, how healthcare teams can better integrate the voices of families of those with opioid use disorder (OUD), and also shared ideas on how to support and improve retention for clients on opioid agonist therapy (OAT).

Teams from across BC join the BOOST QI Network Annual Congress virtually Read More »

New BC-CfE research improves our knowledge and validation of the HIV reservoir

A recently published paper, in the scientific journal Virus Evolution, by a BC-CfE doctoral student provides a way for phylogenetic and other molecular studies of HIV reservoirs to be validated. This vital research will help in the understanding of the dynamics of the HIV-1 reservoir, thus bringing us closer to a durable HIV-1 cure

New BC-CfE research improves our knowledge and validation of the HIV reservoir Read More »

Scroll to Top

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below